These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35765145)

  • 1. Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation.
    Halloran PF; Reeve J; Madill-Thomsen KS; Kaur N; Ahmed E; Cantos C; Al Haj Baddar N; Demko Z; Liang N; Swenerton RK; Zimmermann BG; Van Hummelen P; Prewett A; Rabinowitz M; Tabriziani H; Gauthier P; Billings P;
    Transplantation; 2022 Dec; 106(12):2435-2442. PubMed ID: 35765145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
    Ventura-Aguiar P; Ramirez-Bajo MJ; Rovira J; Bañón-Maneus E; Hierro N; Lazo M; Cuatrecasas M; Garcia-Criado MA; Liang N; Swenerton RK; Cofan F; Cucchiari D; Esforzado N; Montagud-Marrahi E; Oppenheimer F; Piñeiro G; Revuelta I; Torregrosa V; Ahmed E; Soboleva K; Kaur N; Zimmermann BG; Al Haj Baddar N; Demko ZP; Escrig C; Tabriziani H; Gauthier P; Billings PR; Amor AJ; Ferrer J; Campistol JM; Diekmann F
    Transplantation; 2022 Aug; 106(8):1690-1697. PubMed ID: 35289777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.
    Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J
    Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Gauthier P; Billings P; Lawrence C; Lowe D; Hidalgo LG;
    Transplantation; 2023 Mar; 107(3):709-719. PubMed ID: 36190186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
    Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
    Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management.
    Qazi Y; Patel A; Fajardo M; McCormick S; Fehringer G; Ahmed E; Malhotra M; Demko ZP; Billings PR; Tabriziani H; Gauthier P
    Transplant Proc; 2021 Dec; 53(10):2866-2872. PubMed ID: 34774309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies.
    Gupta G; Moinuddin I; Kamal L; King AL; Winstead R; Demehin M; Kang L; Kimball P; Levy M; Bhati C; Massey HD; Kumar D; Halloran PF
    Transplantation; 2022 May; 106(5):1061-1070. PubMed ID: 34075006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
    Obrișcă B; Butiu M; Sibulesky L; Bakthavatsalam R; Smith KD; Gimferrer I; Warner P; Ismail G; Leca N
    Sci Rep; 2022 Sep; 12(1):15061. PubMed ID: 36064740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.
    Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A
    Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
    Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
    Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived cell-free DNA and renal allograft rejection in surveillance biopsies and indication biopsies.
    Chang JH; Alvarado Verduzco H; Toma K; Sritharan S; Mohan S; Husain SA
    Clin Transplant; 2022 Apr; 36(4):e14561. PubMed ID: 34913202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors.
    Knüttgen F; Beck J; Dittrich M; Oellerich M; Zittermann A; Schulz U; Fuchs U; Knabbe C; Schütz E; Gummert J; Birschmann I
    Transplantation; 2022 Mar; 106(3):615-622. PubMed ID: 33653997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation.
    Dandamudi R; Gu H; Goss CW; Walther L; Dharnidharka VR
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1646-1655. PubMed ID: 36302566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
    Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
    Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.